Skip to content
MarketScale
‹ Back to IndustriesEngineering & Construction

How Coronavirus is Transforming the Automation Industy

While employees in most industries have the opportunity to work from home during the pandemic, this is not the case for those in the manufacturing sector. As a company that deals almost exclusively with physical products, FANUC Robotics started cycling employees into its Michigan headquarters once their governor gave the green light. But how…

This story was produced through MarketScale. See how Engineering & Construction teams put it to work with Partner & Channel Enablement.

Share

While employees in most industries have the opportunity to work from home during the pandemic, this is not the case for those in the manufacturing sector. As a company that deals almost exclusively with physical products, FANUC Robotics started cycling employees into its Michigan headquarters once their governor gave the green light.

But how have its employees adjusted to new workplace expectations?

Advanced Automation host Joe Gemma reached out to Mike Cicco, President and CEO of FANUC in America, to learn how his company is faring during the pandemic and how the coronavirus will impact the automation industry as a whole.

Compared to other industries, business is booming for FANUC. Cicco recounted how companies reached out to them in the first few days of shutdown for robots to build ventilators, masks, test kits and more.

“We saw a large growth in robot sales during that time, almost exclusively due to the pandemic,” he said.

He also noted that many manufacturing organizations with global supply chain networks were severely impacted by the effects of the pandemic in different countries. Because of that, business leaders are now looking to diversify their supply chains and keep things local where possible. However, this is a movement that has been taking shape for years.

“It may have highlighted it or accelerated it in some ways, but the concept of reshoring or localizing or diversifying a supply chain – the pandemic hasn’t created these concepts,” Cicco said. “It’s just something we’re talking about more today.”

Listen to the full episode for the latest insights from thought leaders and experts in the world of automation.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Engineering & Construction: are you visible to AI?

Before they reach out, Engineering & Construction buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Engineering & Construction expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Engineering & Construction expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Engineering & Construction Insights

What Challenges Are Manufacturers Facing Under Annex 1?

What Challenges Are Manufacturers Facing Under Annex 1?

Manufacturers are facing significant challenges under Annex 1, which regulates sterile production processes. Compliance with these regulations is critical for maintaining product safety and quality. Identifying potential risks and implementing effective control measures are key aspects for manufacturers to address.

  • 01Annex 1 presents challenges in maintaining sterile production processes for manufacturers.
  • 02Compliance with Annex 1 regulations is crucial for product safety and quality.
  • 03Manufacturers must identify risks and implement effective control measures.

Aug 3, 2026

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

Pharmaceutical manufacturers face significant challenges such as ensuring quality control, navigating regulatory requirements, and managing supply chain disruptions. These issues are intensified by the need for innovation and rapid response to market demands. Companies must balance these factors to remain competitive in the industry.

  • 01Quality control is a major challenge for pharmaceutical manufacturers.
  • 02Regulatory compliance is essential but can be complex and time-consuming.
  • 03Supply chain disruptions require strategic management and contingency planning.

Aug 3, 2026

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

Industrial real estate construction in the U.S. reached over 305 million square feet in the second quarter of 2026, an 18% increase from the previous year. The surge is largely driven by demand from data-center equipment suppliers. This trend highlights the growing influence of data centers on industrial real estate recovery.

  • 01U.S. industrial real estate construction increased by 18% year-over-year in Q2 2026.
  • 02Demand for new constructions is primarily driven by data-center equipment suppliers.
  • 03Over 305 million square feet of industrial space is under development.

Aug 1, 2026

Explore More Engineering & Construction Insights

Read more expert perspectives from across Engineering & Construction.

Browse Engineering & Construction Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Engineering & Construction and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512